Clinical Trials Browser

Phase 2 × Recruiting × CTL019 chimeric antigen receptor × Clear all

NCT05633615 2026-02-02

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Phase 2 Recruiting

Lymphoma, Large B-Cell, Diffuse